Switch to a Calcium Channel Blocker (CCB) or Thiazide Diuretic
For a patient experiencing dizziness on losartan, switch to a calcium channel blocker (such as amlodipine 5-10 mg daily) or a thiazide diuretic (chlorthalidone 12.5-25 mg daily) today. These are first-line alternatives that avoid the ARB class entirely and have lower rates of dizziness-related discontinuation.
Why This Switch Makes Sense
Dizziness is a recognized adverse effect of losartan, occurring in approximately 3-14% of patients 1, 2. The FDA label specifically lists low blood pressure (hypotension) as a serious side effect that may cause dizziness, and instructs patients to "lie down if you feel faint or dizzy" and "call your doctor right away" 1. This symptom represents either:
- Excessive BP lowering (orthostatic hypotension)
- Drug-specific intolerance to ARBs
Recommended Alternative Medications
Based on the 2024 ESC and 2017 ACC/AHA guidelines, first-line antihypertensive agents include 3, 4:
Option 1: Calcium Channel Blocker (Preferred)
- Amlodipine 2.5-10 mg once daily 4
- Advantages: Effective BP control, once-daily dosing, different mechanism of action
- Caution: May cause dose-related pedal edema (more common in women)
- Alternative CCBs: Felodipine 2.5-10 mg daily or nifedipine LA 30-90 mg daily
Option 2: Thiazide Diuretic
- Chlorthalidone 12.5-25 mg once daily (preferred over HCTZ due to longer half-life and proven CVD reduction) 4
- Advantages: Proven mortality benefit, inexpensive
- Monitoring: Check electrolytes (sodium, potassium), uric acid, and calcium levels
What NOT to Do
Avoid switching to another ARB (valsartan, irbesartan, etc.) as they share the same mechanism and similar side effect profiles, including dizziness 5. While some studies suggest minor tolerability differences between ARBs, dizziness remains a class effect.
Do not switch to another ACE inhibitor unless specifically indicated, as they also block the renin-angiotensin system and can cause similar hypotensive effects, though they have the additional burden of dry cough (8.8% incidence) 2.
Clinical Approach Today
- Discontinue losartan immediately - no taper needed for ARBs
- Start amlodipine 5 mg daily OR chlorthalidone 12.5 mg daily
- Check orthostatic vital signs to confirm if hypotension is present (BP drop >20/10 mmHg upon standing)
- Recheck BP in 2-4 weeks to ensure adequate control
- If BP remains elevated, titrate the chosen agent upward or add a second agent from a different class per guideline-directed combination therapy 3
Important Caveats
If the patient has specific indications for ARB therapy (diabetic nephropathy, heart failure with reduced ejection fraction, post-MI), the dizziness may represent over-treatment rather than intolerance. In this case, reduce the losartan dose to 25 mg daily first before abandoning the class entirely.
If dizziness is severe or associated with syncope, rule out other causes including dehydration, concurrent diuretic use, autonomic dysfunction, or cardiac arrhythmias before attributing it solely to losartan.
The 2024 ESC guidelines emphasize combination therapy for most patients 3, so if this patient requires multiple agents for BP control, a CCB + thiazide combination would be appropriate and avoids the RAS blockade that caused symptoms.